Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Stocks
Currencies
Cryptocurrencies
Metals
Indices
Commodities
ETFs
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
News
Top Providers News
Top Providers News
Symbols
Market
Provider
Time
Symbols
News
Provider
4 hours ago
Summit Therapeutics Faces FDA Hurdle For Lead Lung Cancer Drug, Stock Tumbles
Benzinga
4 hours ago
HomesToLife Completes $6.75M Offering Of 7.5M Shares At $0.90/Share
Benzinga
4 hours ago
Stifel Maintains Buy on HMH Holding, Lowers Price Target to $25
Benzinga
4 hours ago
Invivyd Q3 EPS $(0.10) Beats $(0.13) Estimate, Sales $15.449M Beat $15.033M Estimate
Benzinga
4 hours ago
newcleo And Curio To Collaborate On Supply Of Recycled Used Nuclear Fuel And Transuranic Materials For Production Of Mixed-Oxide Fuel At newcleo’s Planned US Fuel Manufacturing Facility
Benzinga
4 hours ago
Update: Cypherpunk Technologies Q3 Adj. EPS $0.01 Misses $0.04 Estimate, Sales $9.913M Miss $16.200M Estimate
Benzinga
4 hours ago
DUKE Robotics Q3 EPS $(0.24) Misses $(0.11) Estimate, Sales $299.000K Miss $1.200M Estimate
Benzinga
4 hours ago
Starwood Property Trust Chairman And CEO Barry Sternlicht Buys 1.245M Shares For ~$14.7M On Behalf Of His Foundation; Board Vice Chair Jonathan Pollack Buys 169,800 Shares For ~$2.01M
Benzinga
4 hours ago
Needham Maintains Buy on Gemini Space Station, Lowers Price Target to $6
Benzinga
4 hours ago
Mizuho Maintains Outperform on NVIDIA, Lowers Price Target to $220
Benzinga
4 hours ago
Faeth Therapeutics Enters Into Clinical Trial Collaboration And Supply Agreement With Roche To Evaluate PIKTOR In Combination With Investigational Medicine Giredestrant In Patients With HR+/HER2- Advanced Breast Cancer
Benzinga
4 hours ago
Mizuho Maintains Outperform on Figure Technology, Lowers Price Target to $46
Benzinga
4 hours ago
Instil Bio Q3 Adj. EPS $(0.48) Misses $(0.17) Estimate
Benzinga
4 hours ago
HC Wainwright & Co. Maintains Buy on NeuroPace, Lowers Price Target to $12
Benzinga
4 hours ago
Goldman Sachs Maintains Buy on Expand Energy, Lowers Price Target to $103
Benzinga
4 hours ago
Silvia Announces Pilot Partnership With Direxion; Collaboration To Provide ETF And Income-Strategy Educational Content To Users While Creating New Revenue Stream For The Company.
Benzinga
4 hours ago
Lexeo Therapeutics Announces Interim Data From Its Ongoing HEROIC-PKP2 Phase I/II Clinical Trial Of LX2020 For Treatment Of PKP2 Arrhythmogenic Cardiomyopathy; Across Ten Participants, Including Nine With At Least 12 Months Of Follow-up, Treatment With...
Benzinga
4 hours ago
Goldman Sachs Maintains Neutral on Innoviz Technologies, Lowers Price Target to $0.2
Benzinga
4 hours ago
'Soft Recession or Something More Dramatic:' Former SEC Chair Gary Gensler Warns AI Boom Could End in Dot-Com-Scale Bust — 'They Loaned Too Much Money, Too Fast'
Benzinga
4 hours ago
Goldman Sachs Maintains Sell on Gemini Space Station, Lowers Price Target to $3.75
Benzinga
4 hours ago
Highway Holdings Declares Special Cash Dividend Of $0.43228 Per Share
Benzinga
4 hours ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga
4 hours ago
12 Industrials Stocks Moving In Monday's Pre-Market Session
Benzinga
4 hours ago
12 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session
Benzinga
4 hours ago
12 Information Technology Stocks Moving In Monday's Pre-Market Session
Benzinga
4 hours ago
Helus Pharma Announces Topline Results From Its APPROACH Phase 3 Study Evaluating HLP003 For Adults With Major Depressive Disorder; 7.6 Point Placebo-Adjusted Change From Baseline At Week 6 For The Primary Endpoint; Durable Effect Maintained Through...
Benzinga
4 hours ago
Goldman Sachs Maintains Buy on Inter & Co, Lowers Price Target to $8
Benzinga
4 hours ago
Cypherpunk Technologies Q3 EPS $1.13 Beats $0.04 Estimate, Sales $9.913M Miss $16.200M Estimate
Benzinga
4 hours ago
BioLineRx And Hemispherian Present Two Posters Featuring GLIX1 At 31st Society For Neuro-Oncology Annual Meeting
Benzinga
4 hours ago
Goldman Sachs Downgrades YETI Holdings to Neutral, Lowers Price Target to $41
Benzinga
1
...
7
8
9
10
11
12
...
709
>